Zhitong Financial APP News, Shanghai Fosun Pharmaceutical (600196.SH) announced that the company's holding subsidiaries Shanghai Fosun Health Technology (Group) Co., Ltd. ("Fosun Health") and Ningbo compound Medical Technology Co., Ltd. ("Ningbo compound Technology") plan to increase the capital of Shanghai Fuyun Health Technology Co., Ltd. ("Fuyun Health") together with Hainan Yunzhi (Fuyun Health employee shareholding platform). Fosun Health and Ningbo compound Technology plan to contribute 8.5 million yuan respectively. After the completion of this capital increase, the group (through Fosun Health and Ningbo compound Technology) will hold a total of about 56.6666% of Fuyun Health, and Fuyun Health will be included in the group's consolidated statement.

It is reported that Fuyun Health is committed to building an one-stop health management service platform for the elderly and chronically ill groups. At present, its main product is the Star Guardian smartwatch, which provides real-time health monitoring services, such as health monitoring, heart and brain health warning, SOS one-click rescue, online consultation and other services. The capital increase will be used for Fuyun Health's product research and development and channel development. This investment will help to enrich the business layout of the Group in the field of smart wearable devices.